Table 1.
Initial (T1) parameters and pairwise comparisons (t test/Mann–Whitney test) for REH, CON and Non-clinical groups.
| (A) | ||||||||||||
| Variable | REH | CON | REH vs. CON | Non-Clinical | REH vs. Non-Clinical | |||||||
| M | SD | M | SD | t t/U U | p | M | SD | t t/U U | p | |||
| d2-TN | 304.63 | 36.99 | 330.65 | 36.99 | 1.79 t | 0.083 | ||||||
| d2-Errors | 144.06 | 23.51 | 137.71 | 23.51 | −0.42 t | 0.675 | ||||||
| d2-%Errors | 47.71 | 8.71 | 43.23 | 8.71 | −0.79 t | 0.436 | ||||||
| d2-TN-E | 160.56 | 38.83 | 192.94 | 38.83 | 1.45 t | 0.158 | ||||||
| d-CP | 110.69 | 29.77 | 134.06 | 41.17 | 130.00 U | 0.843 | ||||||
| d-FR | 15.25 | 29.77 | 15.94 | 41.17 | 87.00 U | 0.081 | ||||||
| CTT-1 | 60.56 | 24.74 | 58.94 | 26.03 | 127.50 U | 0.773 | ||||||
| CTT-2 | 126.06 | 39.58 | 123.12 | 55.48 | 120.50 U | 0.589 | ||||||
| CTT-II | 1.19 | 0.59 | 1.12 | 0.51 | 126.00 U | 0.732 | ||||||
| BCIS-REF | 20.81 | 3.53 | 22.94 | 5.26 | 114.00 U | 0.439 | ||||||
| BCIS-CER | 14.44 | 0.99 | 16.12 | 3.77 | 1.28 t | 0.210 | ||||||
| BCIS-INDEX | 6.38 | 2.50 | 6.82 | 4.07 | 0.38 t | 0.707 | ||||||
| AIS-Total | 26.44 | 9.12 | 29.06 | 6.98 | 0.93 t | 0.359 | ||||||
| AIS (1–2 items) | 6.69 | 2.47 | 7.00 | 2.53 | 121.50 U | 0.614 | ||||||
| AIS (3–8 items) | 19.75 | 7.25 | 22.06 | 5.15 | 1.06 t | 0.298 | ||||||
| GSES-Total | 28.88 | 7.25 | 31.59 | 6.27 | 1.15 t | 0.258 | ||||||
| GSES-6 (items) | 17.81 | 4.21 | 19.00 | 3.89 | 119.50 U | 0.564 | ||||||
| PANSS Total | 53.13 | 7.29 | 53.41 | 15.73 | 119.0 U | 0.552 | ||||||
| Age of first hospitalization (years) | 22.69 | 3.36 | 25.12 | 5.10 | 1.61 t | 0.119 | ||||||
| DUP (years) |
2.00 | 1.10 | 2.59 | 1.37 | 1.35 t | 0.185 | ||||||
| Education (ISCED grades) | 3.50 | 1.10 | 3.35 | 0.49 | −0.05 t | 0.619 | ||||||
| Antipsychotics in milligrams (equivalents of olanzapine) | 21.28 | 6.88 | 19.32 | 4.97 | 121.5 U | 0.614 | ||||||
| NPS (pg/mL) | 48.46 | 16.32 | 39.67 | 7.14 | 82.5 U | 0.061 | 42.97 | 16.55 | 64.0 U | 0.360 | ||
| BMI (kg/m2) | 29.84 | 4.05 | 27.39 | 2.81 | −2.02 t | 0.052 | 28.85 | 3.88 | 0.69 t | 0.496 | ||
| Age (years) | 36.00 | 7.79 | 39.35 | 10.65 | 1.03 t | 0.312 | 41.27 | 7.48 | −1.92 t | 0.065 | ||
| (B) | ||||||||||||
| Variable | REH | CON | Non-Clinical | H-Test | ||||||||
| Ranks Sum | Ranks Mean | Ranks Sum | Ranks Mean | Ranks Sum | Ranks Mean | H | p | |||||
| NPS (pg/mL) | 479.5 | 29.97 | 400.5 | 23.56 | 296.0 | 19.73 | 4.26 | 0.1189 | ||||
| BMI (kg/m2) | 464.0 | 29.00 | 345.0 | 20.29 | 367.0 | 24.47 | 3.19 | 0.2032 | ||||
| Age (years) | 310.0 | 19.38 | 437.5 | 25.74 | 428.5 | 28.57 | 3.56 | 0.1690 | ||||
(A): REH—patient rehabilitation group, CON—patient control group, Non-clinical—healthy reference group, d2-TN—d2 total number, d2-E—d2 errors, d2-E%—d2 percentage of all errors, d2-TN-E—d2 total number minus all errors, d2-CP—concentration performance, d2-FR—d2 fluctuation rate, CTT—Color Trails Test, CTT-II—interference index, BCIS—Beck Cognitive Insight Scale (reflectiveness, certainty), AIS—Acceptance of Illness Scale, GSES—General Self-Efficacy Scale, PANSS Total—total result of Positive and Negative Syndrome Scale, DUP—duration of untreated psychosis, ISCED—International Standard Classification of Education, NPS—Neuropeptide S, BMI—body mass index, M—mean, SD—standard deviation, t—Student’s t-test, U—Mann-Whitney U-test, p—p-value significance at p < 0.05. (B): REH—patient rehabilitation group, CON—patient control group, non-clinical—healthy reference group, NPS—Neuropeptide S, BMI—body mass index, H-test—Kruskal-Wallis H-test by ranks, p—p-value significance at p < 0.05.